Work

Abstract CT170: ALTAS: A phase II trial of anlotinib in combination with TAS-102 in patients with metastatic colorectal cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct170

Authors: Qing Liu, Chi Zhang, Xiaojing Xu, Yiyi Yu, Tianshu Liu

Institutions: Fudan University, Zhongshan Hospital

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409823131

Cites:

Cited by:

Related to: 10